ArticleDiabetes, obesity & metabolism2026
Correction to "An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in the renal capillaries and protects the capillary network in the diabetic rats".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.